Category: 3. Business

  • A million young people aren’t in a job or training. Britain has a problem | Richard Partington

    A million young people aren’t in a job or training. Britain has a problem | Richard Partington

    Almost a million young people are not in education, employment or training. Employers are freezing their hiring plans. Unemployment is at a four-year high. Not all is right in the UK jobs market, and the outlook is getting worse.

    Typically it takes a full-blown recession to spark the type of growth in unemployment that Britain is witnessing today. About 100,000 jobs have been lost from company payrolls in the past year, and the official jobless rate has hit 4.8%, up from 4.1% a year earlier. More than 9 million working-age adults are neither in employment nor looking for a job.

    But while this alone ought to be worrying enough, underneath these headline statistics are two troubling trends: a dramatic increase in youth unemployment and rising levels of ill health.

    This week the government will respond. Sir Charlie Mayfield, a former chair of John Lewis , is expected to publish his Keep Britain Working review, outlining his recommendations for the government and business to do more to tackle rising levels of worklessness.

    Commissioned by ministers last year, Mayfield believes businesses must do significantly more to help people with work-limiting health conditions and those with disabilities. Support for mental health in particular is key.

    “This issue is a nasty one,” Mayfield told me recently at Labour’s party conference in Liverpool. “There is a tremendous opportunity to do better.

    “It is absolutely huge in the context of what it means for those people individually, in terms of what it means for the productive capacity that is not then available to the economy, and therefore the implications that has for growth.”

    As many as one in five working-age adults across the country are either not in employment or currently seeking a job, a position statisticians describe as “economically inactive”. For almost 3 million, the main reason is long-term ill-health, which is near to its highest level on record.

    Most of the increase has been down to the health of young people. Between 2015 and 2024, the number of people with work-limiting conditions rose by 900,000, or 32%, for 50- to 64-year-olds. For those aged 16 to 34, the rise was 1.2 million, or 77%.

    More than a quarter of 16- 24-year-olds who are not in education, employment or training (Neet) are inactive because of disability and ill-health, according to the Resolution Foundation. That figure has more than doubled since 2005.

    Separate analysis published this week by the TUC shows that unemployment for people with disabilities has jumped to the highest rate since before the Covid pandemic, and stands at more than double that of the rate for non-disabled people.

    With the Mayfield review, the TUC chief, Paul Nowak, believes Labour has an opportunity to turn the page on a decade of Tory neglect of disabled workers. But it will require ministers to take action. “Our employment system is failing disabled people,” he said. “We can’t carry on as we are.”

    The big question is how to respond. Who is best placed to help young people, and those with health conditions, to get on in the world of work?

    Ahead of Rachel Reeves’s budget, business leaders have made clear that their capacity to do much more is at breaking point. But with the public finances in a tight spot, the government, too, has limited room for manoeuvre.

    On 26 November, the chancellor will be expected to flesh out her promise of a “youth guarantee”, announced at Labour’s annual conference in Liverpool. Investment in skills, training, apprenticeships and further eduction will also be key. The TUC is warning Reeves against taking a renewed shot at cutting disability benefits, urging her to reform the Access to Work scheme, and to raise statutory sick pay.

    skip past newsletter promotion

    Getting more people into work would be a much better way to cut spending on benefits. It would also benefit the economy: if the UK matched the lowest Neet rate among OECD countries, that could deliver a boost to the economy of £69bn.

    For business, bosses feel in a strong position to push back against any new government requests to play a bigger role. Unless, of course, it involves a tax break or subsidy. After the chancellor’s last budget raised employer national insurance contributions (NICs) by £25bn, corporate lobbyists feel emboldened.

    On the one hand, they have a point. Alongside this tax rise, a higher living wage, elevated borrowing costs, sticky inflation and a sluggish economic outlook, companies are under significant pressure. These headwinds are among the reasons why the jobs market is faltering. Business groups also warn that Labour’s “make work pay” employment rights bill would make matters worse.

    Job vacancies have fallen most in the sectors hurt most by the rising cost of employment and fading consumer demand; retail, leisure and hospitality are among the hardest hit. However, these places are also typically the first ports of call for young people and those with health issues who are hoping to get back into the jobs market.

    But employers refusing to do more to help them would be massively short-termist. Without support, the rise in people standing outside the jobs market will deprive business of potential employees and customers; unemployment would rise further, the economy would suffer, and the public finances would deteriorate. Nobody wins.

    “Investment in employee health and wellbeing should not be a burden,” Mayfield told me in Liverpool. “It actually should be something that is both increasingly necessary and also highly returning for employers.

    “What we have to figure out is, how do we create the circumstances where more employers both feel and experience that?”

    Businesses might well be under pressure. But equally they cannot opt out either, and say: “Nothing to do with us.” We live in a society where we are all connected.

    Continue Reading

  • Udemy (UDMY) Valuation in Focus After Q3 Earnings Beat and Shift to Subscription Model

    Udemy (UDMY) Valuation in Focus After Q3 Earnings Beat and Shift to Subscription Model

    Udemy (UDMY) drew investor attention after reporting third-quarter earnings that topped profit and revenue expectations. However, total sales remained unchanged year over year and management offered a cautious revenue outlook for the coming quarter.

    See our latest analysis for Udemy.

    After beating quarterly profit expectations and announcing a shift to a subscription-first model, Udemy’s share price dropped sharply, with a 1-week share price return of -16.4% and a year-to-date slide of nearly 31%. Market momentum is fading as cautious guidance and changing revenue mix temper earlier optimism. This is reflected in a 12-month total shareholder return of -29.2% and an even steeper three-year loss.

    If Udemy’s transformation has you rethinking where to look for growth, now’s a good moment to broaden your search and discover fast growing stocks with high insider ownership

    With shares trading at a steep discount to analyst price targets and management projecting mixed signals ahead, is Udemy an overlooked bargain in the making, or is the market already bracing for slow growth?

    Udemy’s narrative-driven fair value estimate lands at $10.17, which is significantly above the latest close price of $5.70. This valuation hinges on future earnings growth and profitability projections that diverge from the current market stance.

    The shift towards a subscription-based revenue model, now comprising around 70% of overall revenue, provides greater earnings predictability, higher gross margins, and improved bottom-line performance as Udemy Business (B2B) wins larger deals and consumer subscription GMV grows more than 40% year over year. This indicates robust future margin expansion and more stable recurring cash flows.

    Read the complete narrative.

    Want to know what surprising numbers back this bold valuation? The fair value calculation leans on a set of forecasts that project a fast-changing earnings landscape and an ambitious profit trajectory. Curious which assumptions drive this upside? Read the full narrative for all the details lurking beneath the headline.

    Result: Fair Value of $10.17 (UNDERVALUED)

    Have a read of the narrative in full and understand what’s behind the forecasts.

    However, ongoing declines in consumer revenue and heavy reliance on a few large enterprise clients could limit Udemy’s growth and earnings stability in the future.

    Find out about the key risks to this Udemy narrative.

    If this take on Udemy doesn’t quite fit your outlook, why not dive into the details yourself and shape your own view in just minutes. Do it your way

    A good starting point is our analysis highlighting 4 key rewards investors are optimistic about regarding Udemy.

    Why stop now? Expand your portfolio horizons like the pros by targeting stocks poised for big moves in fast-growing and innovative sectors.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Companies discussed in this article include UDMY.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

    Continue Reading

  • Assessing Current Valuation After Recent Share Price Declines

    Assessing Current Valuation After Recent Share Price Declines

    Synovus Financial (SNV) shares have edged up slightly in recent trading, gaining just under 1% and closing at $44.64. Investors are watching how the stock performs after a difficult month, as shares are down 8% over that period.

    See our latest analysis for Synovus Financial.

    Despite a tough stretch recently, Synovus Financial’s 1-year total shareholder return is down just 6.7%, while its five-year total return stands out at more than 100%. Although the short-term share price return has slipped, investors are considering whether the current softness signals the end of last year’s momentum or the beginning of new opportunities as the risk outlook changes.

    If you’re reassessing your next move, it could be the perfect chance to broaden your search and discover fast growing stocks with high insider ownership

    After recent declines and a mixed longer-term track record, the key question is whether Synovus Financial’s current valuation reflects a bargain or if the market has already accounted for the company’s future prospects. Could there still be upside from here?

    With Synovus Financial trading at $44.64 versus a narrative fair value of $56.43, the widely-followed perspective sees substantial upside from current levels. This valuation is anchored in optimistic assumptions about core business drivers and expansion opportunities following the pending Pinnacle merger.

    Accelerated investments in digital banking (e.g., loan origination, treasury management tools, payment modernization) and successful fintech partnerships are enhancing operational efficiency and improving customer loyalty. This should improve net margins and support higher fee-based income.

    Read the complete narrative.

    Curious how these digital moves are expected to reshape profit margins and fee income for years to come? There is a bold underlying strategy embedded in this valuation forecast, involving business banking momentum, predicted revenue boosts, and future earnings multiples that might surprise you. If you want to know how the future earnings lens builds this bullish target, there is only one place to see what is driving the forecast.

    Result: Fair Value of $56.43 (UNDERVALUED)

    Have a read of the narrative in full and understand what’s behind the forecasts.

    However, significant merger execution risks and ongoing commercial real estate headwinds could quickly challenge the optimistic outlook that is reflected in current valuations.

    Find out about the key risks to this Synovus Financial narrative.

    If you see the story differently or want to run the numbers your own way, you can quickly build your own take in just a few minutes, so why not Do it your way

    A good starting point is our analysis highlighting 5 key rewards investors are optimistic about regarding Synovus Financial.

    Step beyond the obvious and open the door to stocks with surprising potential by using the right investment tools. You could miss out on unique opportunities by staying in your comfort zone.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Companies discussed in this article include SNV.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

    Continue Reading

  • Mitani Sangyo (TSE:8285) Earnings Growth of 22% Reinforces Narrative of Consistent Profitability

    Mitani Sangyo (TSE:8285) Earnings Growth of 22% Reinforces Narrative of Consistent Profitability

    Mitani Sangyo (TSE:8285) delivered 22% earnings growth over the past year, surpassing its own five-year average of 11.2% per year. The company’s net profit margin edged up to 2.7% from 2.5%, while the Price-To-Earnings Ratio sits at 10.2x, a touch above both peer and sector averages. With the current share price of ¥499 trading below an estimated fair value of ¥675.23, investors may be drawn to Mitani Sangyo’s impressive consistency in profit growth and improving margins. This is especially notable given the absence of disclosed risks and a handful of attractive reward factors such as steady growth and dividend appeal.

    See our full analysis for Mitani Sangyo.

    Next, we will compare these headline numbers to some of the most watched narratives in the market and see where the data supports or potentially challenges prevailing opinions.

    Curious how numbers become stories that shape markets? Explore Community Narratives

    TSE:8285 Earnings & Revenue History as at Nov 2025
    • Net profit margin improved to 2.7% from 2.5%, offering a modest uplift given Japan’s often slim margins in trading and distribution.

    • What is notable is how this margin uptick supports the narrative that Mitani Sangyo’s diversified model can weather sector challenges while delivering stability to shareholders.

      • The margin increase, though small, signals operational discipline and potentially greater pricing power, traits that are valued in a defensive stock.

      • With historical average annual earnings growth of 11.2% and headline earnings up 22% this year, the company is achieving stronger profitability without taking on greater risk.

    • Trading at a Price-To-Earnings Ratio of 10.2x, Mitani Sangyo sits slightly above its peer average (9.8x) and the industry average (10.1x). However, the current share price of ¥499 remains well below the DCF fair value of ¥675.23.

    • The prevailing view is that investors paying a small premium over peers may still find value, since the shares currently trade at an approximate 26% discount to DCF fair value.

      • This difference between peer multiples and intrinsic value could attract buyers looking for safety and steady returns in an uncertain macro environment.

      • There is a tension: some may hesitate at the slight P/E premium, but the significant gap to DCF suggests more potential than typical value traps offer.

    • The filing signals high-quality earnings, a five-year profit growth trend of 11.2% per year, and no major or minor risks identified in the current disclosure.

    • This combination strongly supports the view that Mitani Sangyo is a defensive choice, delivering solid long-term performance and dividend reliability despite lacking more prominent growth catalysts.

      • The absence of risk warnings reinforces confidence in the company’s ability to keep executing, which is particularly attractive to investors seeking steady income or stability.

      • Reward factors highlighted in the filing, such as a consistent growth record and regular dividends, add a layer of reassurance seldom seen without at least minor risk disclosures.

    Continue Reading

  • Bessent says high US interest rates may have caused housing recession – Reuters

    1. Bessent says high US interest rates may have caused housing recession  Reuters
    2. Bessent Says Some ‘Sectors’ Of Economy Are In Recession  Forbes
    3. U.S. Treasury Secretary: If inflation falls, the Federal Reserve should cut interest rates  Bitget
    4. Bessent: Fed should cut rates if inflation drops  breakingthenews.net
    5. Bessent: U.S. faces broader recession risk without more Fed cuts  axios.com

    Continue Reading

  • Evaluating the Quality of Patient Handoff Communication in the Department of Medicine at Dongola Specialized Hospital

    Evaluating the Quality of Patient Handoff Communication in the Department of Medicine at Dongola Specialized Hospital


    Continue Reading

  • US probes near miss between Southwest Airlines jet and helicopter

    US probes near miss between Southwest Airlines jet and helicopter

    • Incident occurred on October 29 near Cleveland airport
    • The aircraft came within a half mile (0.9 km) in the air
    WASHINGTON, Nov 2 (Reuters) – The U.S. National Transportation Safety Board said on Sunday it is sending a team to investigate an October 29 close call between a Southwest Airlines (LUV.N), opens new tab jet and a medical helicopter near Cleveland International Airport in Ohio.

    The NTSB said the two aircraft experienced a loss of separation – meaning they came closer to each other than the required minimum safe distance – when Southwest Flight 1333 was making its final approach on a flight from Baltimore-Washington International Thurgood Marshall Airport (BWI).

    Sign up here.

    This prompted the Southwest pilot to abort the landing. Southwest said the Boeing 737 (BA.N), opens new tab landed safely a short time later.

    The NTSB and Southwest did not disclose the number of passengers and crew aboard the airliner. The helicopter appears to have been transporting a patient at the time of the incident, based on how it was identifying itself at the time.

    Southwest said in a statement on Sunday it “appreciates the professionalism of our crew in responding to the situation. We are engaged with the National Transportation Safety Board and will support the investigation.”

    A representative for the medical transport company did not immediately respond to a request for comment.

    A mid-air collision between an American Airlines (AAL.O), opens new tab regional jet and a U.S. Army helicopter on January 29 killed 67 people near Ronald Reagan Washington National Airport outside the U.S. capital and caused alarm about close calls between commercial airplanes and helicopters.

    Aviation tracking website Flightradar24 said air traffic control audio and flight tracking showed that the Southwest plane was forced to deviate from its course to avoid the Eurocopter helicopter that was passing in front of it in the Cleveland incident. Both aircraft were at 2,075 feet (632 meters) altitude at one point and were as close as 0.56 miles (0.9 km) of separation, the site said.

    An air traffic controller asked the medical helicopter to go behind the other flight traffic in the vicinity of the airport but the helicopter pilot responded that it “would be better if we could go above it and in front of it if we can,” and the controller agreed, according to audio posted by Flightradar24.

    The Southwest captain said in a report to the Federal Aviation Administration that it was an “extremely close” incident and required immediate action to avoid a collision, according to two people briefed on the matter.

    The FAA last month said it was modifying helicopter routes in the vicinity of BWI and Washington Dulles International Airport to add buffer zones after the January crash as well as at Reagan.

    The FAA has faced criticism from U.S. lawmakers and NTSB investigators for failing to act on reports of near-miss incidents before the January 29 collision. The Army Black Hawk helicopter was above the maximum permitted altitude at the time of the crash. Both the helicopter and airliner crashed into the Potomac River.

    In May, the FAA barred the Army from flying helicopters near the Pentagon after a May 1 close call that forced two civilian planes to abort landings.

    The NTSB disclosed in March that since 2021 there had been 15,200 loss of air separation incidents near Reagan between commercial airplanes and helicopters, including 85 close-call events.

    Reporting by David Shepardson; Editing by Will Dunham

    Our Standards: The Thomson Reuters Trust Principles., opens new tab

    Continue Reading

  • Diogo Alpuim Costa: 21-Gene Recurrence Score on Treatment Decisions in Early HR+/HER2- Breast Cancer

    Diogo Alpuim Costa: 21-Gene Recurrence Score on Treatment Decisions in Early HR+/HER2- Breast Cancer

    Diogo Alpuim Costa/oxyclinic.pt

    Diogo Alpuim Costa, Head of the Oncology Department and Medical Day Hospital at Cascais Hospital, Dr. José de Almeida, and Clinical Director at Cascais Hyperbaric Center, shared a post on LinkedIn about a paper he co-authored with colleagues published in Clinical Breast Cancer:

    “Honoured to be part of this fantastic Portuguese group led by Dr. Teresa Padrão and Prof. José Luis Passos Coelho, which allowed us to assess the Portuguese landscape using a 21-Gene Recurrence Score Assay to guide adjuvant treatment decisions in over 1000 patients with hormone receptor–positive (HR+), HER2- Early Breast Cancer.

    Published in Clinical Breast Cancer.

    The key messages of the paper ‘The Use and Impact on Treatment Decision of the 21-Gene Recurrence Score Assay for Patients With HR/HER2– Early Breast Cancer in Portugal: A Nationwide Retrospective Cohort Study’ are:

    • The 21-gene Recurrence Score Assay (Oncotype DX) was widely adopted in Portugal and had a substantial impact on adjuvant chemotherapy decisions in hormone receptor-positive, HER2-negative early breast cancer patients, aligning treatment practice with international pivotal trials.
    • After the publication of the TAILORx trial, adjuvant chemotherapy use decreased in patients with Recurrence Score (RS) ≤16 and increased in those with RS ≥25, especially among younger patients.
    • Progesterone receptor (PR) and Ki-67 were independent predictors of high recurrence scores (RS ≥25), supporting the use of these markers to more selectively apply the 21-gene assay in resource-limited clinical settings.
    • The Johns Hopkins Recurrence Score Estimator (JHRE) showed moderate accuracy (53.6%) and low specificity (47.7%) in predicting high-risk scores, suggesting its limited utility for individual decision-making in clinical practice.
    • Chemotherapy was appropriately avoided in low-risk groups and escalated in high-risk groups following the influence of real-world pivotal trial results, confirming the clinical value of the assay for individualized patient care in Portugal.
    • Recurrence rates were low (2.3% median follow-up 29 months), reflecting careful patient selection for chemotherapy de-escalation using the assay.
    • Real-world national data, such as this study, are essential for guiding clinical decision-making, health policy, and the cost-effective use of genomic tests in routine oncology practice.”

    Title: The Use and Impact on Treatment Decision of the 21-Gene Recurrence Score Assay for Patients With HR+/HER2− Early Breast Cancer in Portugal: A Nationwide Retrospective Cohort Study

    Authors: Teresa Gantes Padrão, Diana Pessoa, Joana Alves Luís, Diogo Alpuim Costa, Mário Fontes e Sousa, Ídilia Pina, Susana Palma de Sousa, Débora Cardoso, Sandra Bento, Joana Simões, Ana Ferreira, Renato Cunha, Diogo Martins-Branco, Tiago Dias Domingues, and José Luís Passos-Coelho

    You can read the Full Article in Clinical Breast Cancer.

    Diogo Alpuim Costa: 21-Gene Recurrence Score on Treatment Decisions in Early HR+/HER2- Breast Cancer

    More posts featuring Diogo Alpuim Costa.

    Continue Reading

  • Analyst Says Broadcom (AVGO) Among the Best AI Semiconductor Stocks to Benefit from Bull Run Until 2030

    Analyst Says Broadcom (AVGO) Among the Best AI Semiconductor Stocks to Benefit from Bull Run Until 2030

    We recently published Top 9 AI and Non-Tech Stocks to Watch Amid Latest Earnings Season. Broadcom Inc (NASDAQ:AVGO) is one of the top AI and non-tech stocks.

    Vivek Arya, semiconductor analyst at Bank of America, said in a recent interview with CNBC that the current bull market for AI semiconductor companies could go for a couple of more years or “perhaps even” until 2030.

    “The reason is that most infrastructure cycles tend to last for a decade or more. We have seen this with 3G and 4G, and we have the 5G cycle that started. So these cycles can last for a decade or more. And if you look at when ChatGPT started, that was in late 22, so we are just basically in the first three years of what could be a decade-long cycle. Now it’s important to understand why this is happening, and I think why this is happening is that there is this virtuous kind of flywheel that we have where there’s infrastructure spending that is leading to the creation of intelligence, which is being monetized, which is then being fed right back into the deployment of more infrastructure, and I think semiconductors are absolutely in the middle of a lot of those very important building blocks.”

    The analyst believes Broadcom Inc (NASDAQ:AVGO) is one of the top AI semiconductor companies positioned well to benefit from this bull cycle.

    Analyst Says Broadcom (AVGO) Among the Best AI Semiconductor Stocks to Benefit from Bull Run Until 2030

    Polen Focus Growth Strategy stated the following regarding Broadcom Inc. (NASDAQ:AVGO) in its third quarter 2025 investor letter:

    “In early August we initiated positions in both NVIDIA and Broadcom Inc. (NASDAQ:AVGO), after having not owned either company over the past 2½ years following the initial wave of enthusiasm around Gen AI. While we have long admired both companies, their highly cyclical business models have made it extremely difficult to forecast future earnings growth with any degree of conviction. Given our approach of seeking durable and persistent earnings growth that compounds over long holding periods, our concern in holding either was that we would be forced to endure a punishing downcycle within our typical holding period – there is very little room that in a concentrated portfolio of 20-30 companies. In fact, pre ChatGPT, NVIDIA had two punishing down cycles over the preceding five years.

    Continue Reading

  • 25% of Warren Buffett’s $315 Billion Portfolio Is Invested in 2 Artificial Intelligence (AI) Stocks

    25% of Warren Buffett’s $315 Billion Portfolio Is Invested in 2 Artificial Intelligence (AI) Stocks

    Legendary investor Warren Buffett took the helm of the holding company Berkshire Hathaway in 1965, and he has led it to fantastic, market-crushing gains. Through the end of 2024, just a year shy of his retirement, Berkshire Hathaway had gained 5,502,284% in per-share market value versus a 39,054% gain for the S&P 500.

    Investors looking to emulate his fantastic success are best off following his advice, or you can easily buy shares of Berkshire Hathaway stock. If you look through the company’s equity portfolio, which is public, you might be surprised to see a few tech stocks.

    Buffett is a fan of value stocks and dividend stocks, and he loves consumer goods. In fact, the two artificial intelligence (AI) stocks he does own — Apple (NASDAQ: AAPL) and Amazon (NASDAQ: AMZN) — are both consumer goods giants, and AI can drive further growth for both of them.

    Image source: Getty Images.

    Apple is one of a trio of stocks that Buffett said he would never sell. While many people would label it a tech company, Buffett loves the consumer goods aspect of its business. It sells lots of devices to lots of people, and the interconnected system creates an Apple community with loyal users and customers who typically buy all-Apple products — iPhones, laptops, and the like.

    The iPhone is its premier product, accounting for about half of total revenue. Users love its design, quality, features, and more. Once converted, they typically don’t look back.

    Although fans are known to upgrade to new models, it often takes a few years. Recently, there have been higher sales from customers who upgraded when digital became more important during the pandemic.

    Increasing iPhone sales have greater implications than simply adding to the top line. Investors and analysts have been worried about the trajectory of Apple Intelligence, which seems to be behind other AI programs.

    But increasing iPhone sales are a clear indication that customers are happy with their devices, that the level of AI is working for them, and that there are other features that may be more important. This is Apple’s edge, and it’s why Buffett loves it.

    Amazon truck.
    Image source: Amazon.

    Amazon is only a small fraction of Buffett’s portfolio, but it packs a mean punch. It’s one of the most important AI companies in the world, and combined with its consumer focus, Amazon still has incredible long-term opportunities.

    The AI business runs on Amazon Web Services (AWS), the cloud services segment. The company has developed a large platform offering all kinds of services, including the tools for developers to build their own large language models (LLMs), as well as to engage with an assortment of LLMs through its Bedrock program.

    Amazon is investing hundreds of millions of dollars in its AI business, and it’s already paying off: It has a run rate of more than $100 billion, and management thinks it’s just getting started. “Every single area that I can think of in the way we work is likely going to be impacted in some meaningful way by AI,” CEO Andy Jassy has said.

    And it’s still in its early stages. The company is developing its own chips and hardware to offer budget options and compete on price, and it has a long-term vision as it sets up its AI business. That means investing in powerful data centers that can support AI capabilities for its AWS clients.

    It’s important to note that, as with Apple, Buffett didn’t buy Amazon stock for exposure to AI; he’s not a big fan of the technology. The two investments stand out for many reasons, and one of them is that they offer so much more besides the AI opportunity.

    Before you buy stock in Apple, consider this:

    The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Apple wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

    Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $603,392!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,241,236!*

    Now, it’s worth noting Stock Advisor’s total average return is 1,072% — a market-crushing outperformance compared to 194% for the S&P 500. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

    See the 10 stocks »

    *Stock Advisor returns as of October 27, 2025

    Jennifer Saibil has positions in Apple. The Motley Fool has positions in and recommends Amazon, Apple, and Berkshire Hathaway. The Motley Fool has a disclosure policy.

    25% of Warren Buffett’s $315 Billion Portfolio Is Invested in 2 Artificial Intelligence (AI) Stocks was originally published by The Motley Fool

    Continue Reading